Systems and methods for controlling and forming polymer gels
Abstract
In preferred embodiments, the present invention provides methods of controllably making a vinyl polymer hydrogel having desired physical properties without chemical cross links or radiation. The gelation process is modulated by controlling, for example the temperature of a resultant vinyl polymer mixture having a gellant or using active ingredients provided in an inactive gellant complex. In accordance with a preferred embodiment the method of manufacturing a vinyl polymer hydrogel includes the steps of providing a vinyl polymer solution comprising a vinyl polymer dissolved in a first solvent; heating the vinyl polymer solution to a temperature elevated above the melting point of the physical associations of the vinyl polymer, mixing the vinyl polymer solution with a gellant wherein the resulting mixture has a higher Flory interaction parameter than the vinyl polymer solution: inducing gelation of the mixture of vinyl polymer solution and gellant; and controlling the gelation rate to form a viscoelastic solution wherein workability is maintained for a predetermined period thereby making a vinyl polymer hydrogel having the desired physical property. In further preferred embodiments the present invention provides physically crosslinked hydrogels produced by controlled gelation of viscoelastic solution wherein workability is maintained for a predetermined period. In another aspect, the present invention provides kits for use in repairing intervertebral disks or articulated joints including components that form the vinyl polymer hydrogel and a dispenser.
Claims
exact text as granted — not AI-modified1 - 163 . (canceled)
164 . A physically cross-linked gel produced by the method of comprising: dissolving a biocompatible vinyl polymer in a first solvent to form a vinyl polymer solution; introducing the vinyl polymer solution in a volume of a second solvent to cause gelation, the second solvent having a higher Flory interaction parameter at a process temperature than the vinyl polymer solution to form a biocompatible cross-linked gel, and wherein the cross-linked gel is suitable for in vivo use.
165 . The physically cross-linked gel of claim 164 wherein the vinyl polymer is polyvinyl alcohol having a molecular weight of about 50 kg/mol to about 300 kg/mol.
166 . The physically cross-linked gel of claim 164 wherein the vinyl polymer solution is an aqueous solution of about 10 weight percent to about 30 weight percent polyvinyl alcohol based on the weight of the solution.
167 . The physically cross-linked gel of claim 164 wherein the vinyl polymer solution is introduced in an aqueous solution of sodium chloride from about 1.5 molar to about 6.0 molar.
168 . The physically cross-linked gel of claim 164 wherein the vinyl polymer solution is introduced in an aqueous solution of sodium chloride from about 1.5 molar to about 3.0 molar.
169 . The physically cross-linked gel of claim 164 wherein the vinyl polymer solution is introduced in an aqueous solution of sodium chloride from about 1.75 molar to about 6.0 molar.
170 . The physically cross-linked gel of claim 164 further comprising hyaluronic acid.
171 . The physically cross-linked gel of claim 164 further comprising polyacrylic acid.
172 . A physically cross-linked hydrogel substantially free of chemical crosslinkers.
173 . A physically cross-linked hydrogel comprising at least about 10 weight percent polyvinyl alcohol solution gelled by immersion in about 2 to about 3 molar sodium chloride wherein the hydrogel is about 14 percent to about 21 percent physically crosslinked.
174 . The physically cross-linked hydrogel of claim 172 wherein the gel comprises about 12 to about 29 percent polyvinyl alcohol.
175 . The method of claim 173 wherein the vinyl polymer solution contains one or more non-gelling components.
176 . The physically cross-linked hydrogel of claim 172 further comprising hyaluronic acid.
177 . The physically cross-linked hydrogel of claim 172 further comprising polyacrylic acid.
178 . An article of manufacture comprising a vinyl polymer gel having at least one gradient of mechanical properties.
179 . A one-piece prosthetic intervertebral disk comprising a polyvinyl polymer hydrogel wherein the distribution of mechanical properties of the one-piece prosthetic intervertebral disk approximates the spatial distribution of the mechanical properties of the combination of the nucleus pulposis and the annulus fibrosis of the natural intervertebral disk.
180 . The physically crosslinked gel of claim 164 further comprising a therapeutic agent.
181 . A prosthetic intervertebral disk comprising a biocompatible vinyl polymer hydrogel having a desired physical property, wherein the biocompatible vinyl polymer hydrogel is formed by a method comprising the steps of: providing a vinyl polymer solution comprising a vinyl polymer dissolved in a first solvent; mixing the vinyl polymer solution with a gellant, wherein the resulting mixture has a higher Flory interaction parameter than the vinyl polymer solution; inducing gelation of the mixture of vinyl polymer solution and gellant; controlling the gelation rate to form a viscoelastic solution, wherein workability is maintained for a predetermined period, thereby making a biocompatible vinyl polymer hydrogel having the desired physical property; and wherein the biocompatible vinyl polymer hydrogel is suitable for in vivo use.
182 . A prosthetic intervertebral disk comprising a biocompatible vinyl polymer hydrogel having a desired physical property, wherein the biocompatible vinyl polymer hydrogel is formed by a method comprising the steps of: dissolving a vinyl polymer in a first solvent to form a vinyl polymer solution; and introducing the vinyl polymer solution in a volume of a second solvent to cause gelation, the second solvent having a higher Flory interaction parameter at a process temperature then the vinyl polymer solution to form a biocompatible gel, wherein the property of the gel is controlled by controlling the rate of the introduction of the vinyl polymer solution to the second solvent, and wherein the biocompatible gel is suitable for in vivo use.Join the waitlist — get patent alerts
Track US2007167541A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.